Latest Breaking News On - Sandoz international gmbh - Page 6 : comparemela.com

Ankylosing Spondylitis Treatment Market Set to Blossom at US$

Anti-Obesity Drugs Market Size Expected to Touch US$ 14.8 Billion by 2030 at 23% CAGR

The prevalence of obesity around the world has boosted the need for efficient therapies and drugs, including anti-obesity drugs. Pharmaceutical interventions are becoming more and more necessary as obesity rates rise to address these public health concerns.Wilmington, Delaware, Aug. 21, 2023 (GLOBE NEWSWIRE) Global Anti-Obesity Drugs Market is valued at US$ 2.82 billion in 2022 and is expected to grow at a significant CAGR of over 23% over the forecast period of 2023-2030, market report by Ra

Global Muscle Relaxant Drugs Market Set to Surpass $5.79 Billion by 2027, Propelled by Increasing Demand from the Rising Geriatric Population

/PRNewswire/ The "Muscle Relaxant Drugs Global Market Report 2023" report has been added to ResearchAndMarkets.com s offering. The global muscle relaxant.

The global Nifedipine Medication Market is expected to reach US$ 1,936.9 million by 2030, registering a CAGR of 8.5% | Pfizer Inc., Novartis AG, Merck & Co., Inc., AstraZeneca PLC, Teva Pharmaceutical. |

Pfizer, Amneal Pharmaceuticals, and Merck & Co. Lead the

Dublin, Aug. 01, 2023 (GLOBE NEWSWIRE) The "Muscle Relaxant Drugs Global Market Report 2023" report has been added to ResearchAndMarkets.com's.